More access = more potential patients.
The obesity drug market is still in its early innings.
Not holding many longs right now, but Novo Nordisk is one of them.
$CVS $NVO $LLY #GLP1 #Obesity #Stocks #Investing
Want this kind of breakdown on every trade?
Inside Patreon, every position — wins and losses — gets the full plan-execute-manage-review treatment. Daily updates while trades are on. Direct chat with me.
Join on PatreonEducational content only. Trading involves substantial risk. The setup grade and outcome described here are specific to my plan, sizing, and risk tolerance. Do your own work.
Geef een reactie